Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Common Equity (2020 - 2025)

Incannex Healthcare's Common Equity history spans 4 years, with the latest figure at $73.4 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 7514.73% to $73.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $73.4 million, a 7514.73% increase, with the full-year FY2025 number at $13.4 million, up 19.36% from a year prior.
  • Common Equity hit $73.4 million in Q4 2025 for Incannex Healthcare, down from $77.0 million in the prior quarter.
  • Over the last five years, Common Equity for IXHL hit a ceiling of $77.0 million in Q3 2025 and a floor of $964000.0 in Q4 2024.
  • Historically, Common Equity has averaged $24.0 million across 3 years, with a median of $14.1 million in 2024.
  • Biggest five-year swings in Common Equity: crashed 94.89% in 2024 and later surged 7514.73% in 2025.
  • Tracing IXHL's Common Equity over 3 years: stood at $18.9 million in 2023, then crashed by 94.89% to $964000.0 in 2024, then surged by 7514.73% to $73.4 million in 2025.
  • Business Quant data shows Common Equity for IXHL at $73.4 million in Q4 2025, $77.0 million in Q3 2025, and $13.4 million in Q2 2025.